Status:
UNKNOWN
Imaging Study in Advanced Ovarian Cancer
Lead Sponsor:
Charles University, Czech Republic
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18-80 years
Brief Summary
The aim of the study is the assessment of tumour sites critical for the achievement of optimal cytoreduction in patients with advanced ovarian cancer using Ultrasound, CT and WB-DWI/MRI. The study use...
Detailed Description
Patients with abdominal or pelvic mass suspicious of primary ovarian, tubal or peritoneal cancer using subjective assessment by experienced sonographer (principal investigator) will be enrolled in the...
Eligibility Criteria
Inclusion
- Abdominal or pelvic mass suspicious of primary ovarian, tubal or peritoneal cancer using subjective assessment by experienced sonographer.
- Surgery (PDS or IDS) within 4 weeks from the index test.
- 18 \> Age \< 80.
- ECOG (Eastern Cooperative Oncology Group) grade \< 3.
- Patients after NACT can be included.
Exclusion
- Lesions suspected as being borderline ovarian tumors (BOT) on ultrasound.
- Patients with supradiaphragmatic metastases
- Contraindications to CT
- Medical contraindications to surgery
- Refusal or withdrawal of written informed consent
- Time lapse between ultrasound and surgery more than 4 weeks
- Current pregnancy
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03808792
Start Date
January 1 2020
End Date
December 31 2022
Last Update
January 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gynecologic Oncology Center in Prague
Prague, Czechia, 15000